$BLCO
Bausch & Lomb Corp Stock $blco

$blco Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000186074223000008 Filed on February 22, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$931.0M	$996.0M	$3.768B
YoY Change	4.72%	-0.5%	0.08%
Cost Of Revenue	$372.0M	$420.0M	$1.519B
YoY Change	6.9%	4.22%	3.54%
Gross Profit	$559.0M	$576.0M	$2.249B
YoY Change	3.33%	-3.68%	-2.13%
Gross Profit Margin	60.04%	57.83%	59.69%
Selling, General & Admin	$418.0M	$386.0M	$1.478B
YoY Change	21.87%	5.75%	6.41%
% of Gross Profit	74.78%	67.01%	65.72%
Research & Development	$77.00M	$78.00M	$307.0M
YoY Change	0.0%	11.43%	13.28%
% of Gross Profit	13.77%	13.54%	13.65%
Depreciation & Amortization	$91.00M	$93.00M	$135.0M
YoY Change	-4.21%	-7.0%	-67.47%
% of Gross Profit	16.28%	16.15%	6.0%
Operating Expenses	$495.0M	$520.0M	$1.785B
YoY Change	17.86%	3.17%	-8.74%
Operating Profit	-$2.000M	$56.00M	$207.0M
YoY Change	-103.7%	-40.43%	-39.47%
Interest Expense	-$53.00M	-$53.00M	-$134.0M
YoY Change	112.0%	783.33%	1118.18%
% of Operating Profit		-94.64%	-64.73%
Other Income/Expense, Net	-$9.000M		-$13.00M
YoY Change	350.0%		-23.53%
Pretax Income	-$55.00M	-$2.000M	$73.00M
YoY Change	-289.66%	-102.33%	-77.04%
Income Tax	$33.00M	-$2.000M	$58.00M
% Of Pretax Income			79.45%
Net Earnings	-$90.00M	-$1.000M	$6.000M
YoY Change	-550.0%	-101.96%	-96.7%
Net Earnings / Revenue	-9.67%	-0.1%	0.16%
Basic Earnings Per Share	-$0.26		$0.02
Diluted Earnings Per Share	-$0.26	$0.00	$0.02
COMMON SHARES
Basic Shares Outstanding	350.0M shares	350.0M shares	350.0M shares
Diluted Shares Outstanding	350.0M shares		350.2M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$346.0M	$354.0M	$354.0M
YoY Change	82.11%	103.45%	103.45%
Cash & Equivalents	$346.0M	$354.0M	$354.0M
Short-Term Investments
Other Short-Term Assets	$427.0M	$431.0M	$431.0M
YoY Change	120.1%	156.55%	156.55%
Inventory	$697.0M	$628.0M	$628.0M
Prepaid Expenses
Receivables	$714.0M	$724.0M	$724.0M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$2.184B	$2.137B	$2.137B
YoY Change	27.05%	30.7%	30.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.296B	$1.300B	$1.419B
YoY Change	5.8%	6.12%	6.13%
Goodwill	$4.522B	$4.507B
YoY Change	-0.68%	-1.72%
Intangibles	$2.031B	$2.058B
YoY Change	-7.51%	-9.1%
Long-Term Investments
YoY Change
Other Assets	$213.0M	$215.0M	$1.023B
YoY Change	13.3%	19.44%	2.2%
Total Long-Term Assets	$8.985B	$9.007B	$9.007B
YoY Change	-2.21%	-1.97%	-1.97%
TOTAL ASSETS
Total Short-Term Assets	$2.184B	$2.137B	$2.137B
Total Long-Term Assets	$8.985B	$9.007B	$9.007B
Total Assets	$11.17B	$11.14B	$11.14B
YoY Change	2.4%	2.97%	2.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$389.0M	$370.0M	$370.0M
YoY Change	54.98%	54.81%	54.81%
Accrued Expenses	$840.0M	$901.0M	$493.0M
YoY Change	-0.12%	4.77%	-4.46%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$25.00M	$25.00M	$25.00M
YoY Change
Total Short-Term Liabilities	$1.254B	$1.296B	$1.296B
YoY Change	14.84%	17.93%	17.93%
LONG-TERM LIABILITIES
Long-Term Debt	$2.508B	$2.411B	$2.411B
YoY Change	12.97%
Other Long-Term Liabilities	$341.0M	$329.0M	$329.0M
YoY Change	23.55%	10.4%	10.4%
Total Long-Term Liabilities	$2.849B	$2.740B	$2.740B
YoY Change	932.25%	819.46%	819.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.254B	$1.296B	$1.296B
Total Long-Term Liabilities	$2.849B	$2.740B	$2.740B
Total Liabilities	$4.117B	$4.043B	$4.111B
YoY Change	11.54%	184.52%	175.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$84.00M	$6.000M
YoY Change	-520.0%
Common Stock	$8.305B	$8.285B
YoY Change	1.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.983B	$7.033B	$7.033B
YoY Change
Total Liabilities & Shareholders Equity	$11.17B	$11.14B	$11.14B
YoY Change	2.4%	2.97%	2.97%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$90.00M	-$1.000M	$6.000M
YoY Change	-550.0%	-101.96%	-96.7%
Depreciation, Depletion And Amortization	$91.00M	$93.00M	$135.0M
YoY Change	-4.21%	-7.0%	-67.47%
Cash From Operating Activities	-$56.00M	$159.0M	$345.0M
YoY Change	-1966.67%	-1.85%	-60.48%
INVESTING ACTIVITIES
Capital Expenditures	$37.00M	$50.00M	$175.0M
YoY Change	-11.9%	-180.65%	-190.67%
Acquisitions
YoY Change
Other Investing Activities	-$27.00M	-$40.00M	-$40.00M
YoY Change	-2800.0%	110.53%	90.48%
Cash From Investing Activities	-$64.00M	-$90.00M	-$215.0M
YoY Change	56.1%	11.11%	0.47%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net	$6.000M		$13.00M
YoY Change
Cash From Financing Activities	$91.00M	-7.000M	$81.00M
YoY Change	75.0%	-81.08%	-111.38%
NET CHANGE
Cash From Operating Activities	-$56.00M	159.0M	$345.0M
Cash From Investing Activities	-$64.00M	-90.00M	-$215.0M
Cash From Financing Activities	$91.00M	-7.000M	$81.00M
Net Change In Cash	-$22.00M	62.00M	$203.0M
YoY Change	-269.23%	40.91%	-483.02%
FREE CASH FLOW
Cash From Operating Activities	-$56.00M	$159.0M	$345.0M
Capital Expenditures	$37.00M	$50.00M	$175.0M
Free Cash Flow	-$93.00M	$109.0M	$170.0M
YoY Change	138.46%	-51.34%	-84.05%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001860742
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Entity Registrant Name EntityRegistrantName	Bausch & Lomb Corp
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41380
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	Z4
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1613662
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	520 Applewood Crescent
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Vaughan
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	ON
CY2022	dei	Entity Address Country EntityAddressCountry	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	L4K 4B4
CY2022	dei	City Area Code CityAreaCode	905
CY2022	dei	Local Phone Number LocalPhoneNumber	695-7700
CY2022	dei	Security12b Title Security12bTitle	Common Shares, No Par Value
CY2022	dei	Trading Symbol TradingSymbol	BLCO
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	false
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	602747441	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	350000933	shares
CY2022	dei	Auditor Firm AuditorFirmId	238
CY2022	dei	Auditor Name AuditorName	PricewaterhouseCoopers LLP
CY2022	dei	Auditor Location AuditorLocation	Florham Park, New Jersey
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	354000000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	174000000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	26000000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3000000	usd
CY2022Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	724000000	usd
CY2021Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	721000000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	628000000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	572000000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	405000000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	165000000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	2137000000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1635000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1300000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1225000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2058000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2264000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4507000000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4586000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	927000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	933000000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	215000000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	180000000	usd
CY2022Q4	us-gaap	Assets Assets	11144000000	usd
CY2021Q4	us-gaap	Assets Assets	10823000000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	370000000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	239000000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	901000000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	860000000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	25000000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1296000000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1099000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24000000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	329000000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	298000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2411000000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4043000000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1421000000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350000749	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350000749	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350000749	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350000749	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8285000000	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	0	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	6000000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	0	usd
CY2022Q4	blco	Net Parent Investment NetParentInvestment	0	usd
CY2021Q4	blco	Net Parent Investment NetParentInvestment	10364000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1258000000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1035000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7033000000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	9329000000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	68000000	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	73000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7101000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9402000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	11144000000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10823000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3768000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3765000000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3412000000	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1478000000	usd
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1389000000	usd
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1253000000	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	307000000	usd
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	271000000	usd
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	253000000	usd
CY2022	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	244000000	usd
CY2021	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	292000000	usd
CY2020	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	323000000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-13000000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-17000000	usd
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-38000000	usd
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	3561000000	usd
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	3436000000	usd
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	3152000000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	207000000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	329000000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	260000000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	146000000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6000000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11000000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	318000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	290000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	307000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	15000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	193000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17000000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	9000000	usd
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	11000000	usd
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1000000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6000000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	182000000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-18000000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350000000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350000000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350000000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	15000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	193000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17000000	usd
CY2022	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-4000000	usd
CY2021	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	24000000	usd
CY2020	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-9000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-3000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax	-4000000	usd
CY2022	blco	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-10000000	usd
CY2021	blco	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-10000000	usd
CY2020	blco	Other Comprehensive Income Loss Pensionand Other Postretirement Benefit Plans Amortizationor Settlement Recognition OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansAmortizationorSettlementRecognition	-1000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	-14000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	6000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax	3000000	usd
CY2022	blco	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	1000000	usd
CY2021	blco	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	2000000	usd
CY2020	blco	Other Comprehensive Income Loss Defined Benefit Plan Foreign Currency Adjustment Net Of Tax OtherComprehensiveIncomeLossDefinedBenefitPlanForeignCurrencyAdjustmentNetOfTax	-4000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	10000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	-38000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax	13000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-216000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-182000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	173000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-226000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-144000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	160000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-211000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	49000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	143000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	6000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	13000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	4000000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-217000000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	36000000	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	139000000	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	10032000000	usd
CY2020	blco	Decrease In Investment To Affiliate Net DecreaseInInvestmentToAffiliateNet	180000000	usd
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	7000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17000000	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	160000000	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9988000000	usd
CY2021	blco	Decrease In Investment To Affiliate Net DecreaseInInvestmentToAffiliateNet	625000000	usd
CY2021	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	10000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	193000000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-144000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	9402000000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0	usd
CY2022	blco	Net Parent Investment Decrease In Conjunction With Legal Reorganization NetParentInvestmentDecreaseInConjunctionWithLegalReorganization	2200000000	usd
CY2022	blco	Adjustments To Additional Paid In Capital Distributions To Affiliates AdjustmentsToAdditionalPaidInCapitalDistributionsToAffiliates	75000000	usd
CY2022	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	11000000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	46000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	15000000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-226000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7101000000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	15000000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	193000000	usd
CY2020	us-gaap	Profit Loss ProfitLoss	-17000000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	379000000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	415000000	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	442000000	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8000000	usd
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2020	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12000000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2022	blco	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	25000000	usd
CY2021	blco	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	37000000	usd
CY2020	blco	Allowances For Losses On Accounts Receivable And Inventories AllowancesForLossesOnAccountsReceivableAndInventories	30000000	usd
CY2022	blco	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	-90000000	usd
CY2021	blco	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	116000000	usd
CY2020	blco	Deferred Income Tax Noncash Expense Benefit DeferredIncomeTaxNoncashExpenseBenefit	97000000	usd
CY2022	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	4000000	usd
CY2021	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	1000000	usd
CY2020	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	6000000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	62000000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	62000000	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	50000000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	7000000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-12000000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	19000000	usd
CY2022	blco	Derivative Gain Excluded Component DerivativeGainExcludedComponent	6000000	usd
CY2021	blco	Derivative Gain Excluded Component DerivativeGainExcludedComponent	0	usd
CY2020	blco	Derivative Gain Excluded Component DerivativeGainExcludedComponent	0	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	19000000	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1000000	usd
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	95000000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	107000000	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-77000000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	106000000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15000000	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32000000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	7000000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13000000	usd
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-40000000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	189000000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	163000000	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-144000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	345000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	873000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	522000000	usd
CY2022	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	45000000	usd
CY2021	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	0	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	16000000	usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6000000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	175000000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	193000000	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	253000000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17000000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	19000000	usd
CY2020	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	6000000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	22000000	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	14000000	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	9000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-215000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-214000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-256000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2440000000	usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
CY2022	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	13000000	usd
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3000000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	11000000	usd
CY2021	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	10000000	usd
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	7000000	usd
CY2022	blco	Net Borrowings Financing Activities NetBorrowingsFinancingActivities	31000000	usd
CY2021	blco	Net Borrowings Financing Activities NetBorrowingsFinancingActivities	28000000	usd
CY2020	blco	Net Borrowings Financing Activities NetBorrowingsFinancingActivities	0	usd
CY2022	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	2363000000	usd
CY2021	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	730000000	usd
CY2020	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	225000000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81000000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-712000000	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-232000000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8000000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-8000000	usd
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12000000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	203000000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61000000	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238000000	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	192000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380000000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177000000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238000000	usd
CY2022	us-gaap	Notes Issued1 NotesIssued1	2200000000	usd
CY2021	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2020	us-gaap	Notes Issued1 NotesIssued1	0	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF BUSINESS<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Overview</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch + Lomb Corporation (</span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb” or the </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Company”) is a subsidiary of Bausch Health Companies Inc. (</span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">“BHC</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">”) and is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. The Company operates in three reportable segments: (i) Vision Care segment which includes both a contact lens business and a consumer eye care business that consists of contact lens care products, over-the-counter (“OTC”) eye drops and eye vitamins, (ii) Ophthalmic Pharmaceuticals segment which consists of a broad line of proprietary and generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases and (iii) Surgical segment which consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts and vitreous and retinal eye conditions, and includes intraocular lenses and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. See Note 22, “SEGMENT INFORMATION” for additional information regarding these reportable segments.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:107%">Separation of Bausch + Lomb</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 6, 2020, BHC announced its plan to separate Bausch + Lomb into an independent, publicly traded company, separate from the remainder of BHC (the “Separation”), commencing with an initial public offering of Bausch + Lomb's common shares (as further described below). Prior to January 1, 2022, Bausch + Lomb had nominal assets and liabilities. In connection with the B+L IPO (as defined below), BHC transferred to Bausch + Lomb, in a series of steps, all the entities, assets, liabilities and obligations that Bausch + Lomb held upon completion of the B+L IPO pursuant to a Master Separation Agreement (the “MSA”) with BHC. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registration statement related to the initial public offering (the “IPO”) of Bausch + Lomb’s common shares (the “B+L IPO”) was declared effective on May 5, 2022, and Bausch + Lomb’s common shares began trading on the New York Stock Exchange and the Toronto Stock Exchange, in each case under the ticker symbol “BLCO”, on May 6, 2022. Bausch + Lomb also obtained a final receipt to its final Canadian base PREP prospectus on May 5, 2022. Prior to the B+L IPO, Bausch + Lomb was a wholly-owned subsidiary of BHC. On May 10, 2022, a wholly-owned subsidiary of BHC (the “Selling Shareholder”) sold 35,000,000 common shares of Bausch + Lomb, at an offering price of $18.00 per share (less the applicable underwriting discount), pursuant to the Bausch + Lomb prospectuses. In addition, the Selling Shareholder granted the underwriters an option for a period of 30 days from the date of the B+L IPO to purchase up to an additional 5,250,000 common shares to cover over-allotments at the IPO price less underwriting commissions. On May 31, 2022, the underwriters for the B+L IPO partially exercised the over-allotment option granted by the Selling Shareholder and, on June 1, 2022, the Selling Shareholder sold an additional 4,550,357 common shares of Bausch + Lomb at an offering price of $18.00 per share (less the applicable underwriting discount). The remainder of the over-allotment option granted to the underwriters expired. The Selling Shareholder received all net proceeds from the B+L IPO and the partial exercise of the over-allotment option by the underwriters. As of February 17, 2023, BHC directly or indirectly holds 310,449,643 Bausch + Lomb common shares, which represents approximately 88.7% of Bausch + Lomb common shares. </span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The completion of the full Separation of Bausch + Lomb, which includes the transfer of all or a portion of BHC’s remaining direct or indirect equity interest in Bausch + Lomb to its shareholders (the “Distribution”), is subject to the achievement of targeted debt leverage ratios, market conditions and the receipt of applicable shareholder and other necessary approvals and other factors and is subject to various risk factors relating to the Separation. See Item 1A. “Risk Factors” of this Form 10-K for additional information on the risks associated with the Separation. Bausch + Lomb understands that BHC continues to believe that completing the B+L Separation makes strategic sense and that BHC continues to evaluate all factors and considerations related to completing the Separation, including the effect of the lawsuit filed against Norwich Pharmaceuticals Inc. in connection with its Abbreviated New Drug Application ("ANDA") for Xifaxan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">®</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (rifaxamin) 550 mg tablets (including BHC’s ability to successfully appeal the decision of the U.S. District Court for the District of Delaware in such lawsuit).</span></div>
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	22000000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb’s Consolidated Financial Statements, management is required to make estimates and assumptions. This includes estimates and assumptions regarding the nature, timing and extent of the impacts that certain global macroeconomic conditions, including, but not limited to, those related to the COVID-19 pandemic and its overall impact on inflation and supply chain, will have on Bausch + Lomb's operations and cash flows. The estimates and assumptions used by </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include: provisions for product returns, rebates, chargebacks, discounts and allowances and distribution fees paid to certain wholesalers; useful lives of finite-lived intangible assets and property, plant and equipment; expected future cash flows used in evaluating intangible assets for impairment, assessing compliance with debt covenants, reporting unit fair values for testing goodwill for impairment; acquisition-related contingent consideration liabilities; provisions for loss contingencies; provisions for income taxes, uncertain tax positions and realizability of deferred tax assets; the fair value of cross-currency swaps; and the fair value of foreign currency exchange contracts. Prior to the B+L IPO, significant estimates made by management also included the related allocations described in the basis of presentation.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All allocations and estimates in these Consolidated Financial Statements are based on assumptions that management believes are reasonable. On an ongoing basis, management reviews its allocations and estimates to ensure that these allocations and estimates appropriately reflect changes in </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb and new information as it becomes available. If historical experience and other factors used by management to make these estimates do not reasonably reflect future activity, </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb’s Consolidated Financial Statements could be materially impacted.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which certain global macroeconomic conditions, including, but not limited to, those related to the COVID-19 pandemic and its overall impact on inflation and supply chain, may continue to impact </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb’s business, financial condition, cash flows and results of operations, in particular, will depend on future developments which are highly uncertain and many of which are outside </span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb’s control.</span><span style="color:#000000;font-family:'Times',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Bausch</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> + Lomb has assessed the possible effects and outcomes of these macroeconomic conditions on, among other things, its supply chain, customers and distributors, discounts and rebates, employee base, product sustainability, research and development efforts, product pipeline and consumer demand and currently believes that its estimates are reasonable.</span></div>
CY2021Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, trade receivables, cross-currency swaps and foreign currency exchange contracts.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash deposited at banks may exceed the amount of insurance provided on such deposits. Generally, these cash deposits may be redeemed upon demand and are maintained with financial institutions with reputable credit and therefore bear minimal credit risk. The Company seeks to mitigate such risks by spreading its risk across multiple counterparties and monitoring the risk profiles of these counterparties.</span></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the U.S., concentrations of credit risk with respect to trade receivables, which are typically unsecured, are limited due to the number of customers using the Company’s products, as well as their dispersion across many different geographic regions. The Company performs periodic credit evaluations of customers and does not require collateral. The Company monitors economic conditions, including volatility associated with international economies, and related impacts on the relevant financial markets and its business, especially in light of sovereign credit issues. The credit and economic conditions within Argentina, Brazil, Belarus, Greece, Russia, Serbia, South Africa, Turkey, Ukraine and Venezuela have been weak in </span></div>recent years.
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16000000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17000000	usd
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	20000000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4000000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000000	usd
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2000000	usd
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2000000	usd
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2000000	usd
CY2022	blco	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	-4000000	usd
CY2021	blco	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	1000000	usd
CY2020	blco	Accounts Receivable Allowance For Foreign Exchange And Other AccountsReceivableAllowanceForForeignExchangeAndOther	1000000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	16000000	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	17000000	usd
CY2020Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	427000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1276000000	usd
CY2021	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	1235000000	usd
CY2021Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	468000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Charged To Other Accounts ValuationAllowancesAndReservesChargedToOtherAccounts	1376000000	usd
CY2022	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	1360000000	usd
CY2022Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	484000000	usd
CY2022	blco	Cash Discounts And Allowances Settlement Period CashDiscountsAndAllowancesSettlementPeriod	P1M
CY2022	us-gaap	Advertising Expense AdvertisingExpense	319000000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	335000000	usd
CY2020	us-gaap	Advertising Expense AdvertisingExpense	285000000	usd
CY2022	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	63000000	usd
CY2021	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	58000000	usd
CY2022	blco	Tax Benefit Recognition Measurement Percentage TaxBenefitRecognitionMeasurementPercentage	0.50
CY2022	blco	Minimum Period To Classify Uncertain Tax Position Liabilities As Long Term Liabilities MinimumPeriodToClassifyUncertainTaxPositionLiabilitiesAsLongTermLiabilities	P1Y
CY2022	blco	Defined Benefit Plan Actuarial Gain Loss Amortization Threshold Percentage DefinedBenefitPlanActuarialGainLossAmortizationThresholdPercentage	0.10
CY2022	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	76000000	usd
CY2021	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	390000000	usd
CY2020	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	354000000	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	53000000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	6000000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	102000000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	32000000	usd
CY2022Q4	blco	Related Party Net Borrowings RelatedPartyNetBorrowings	0	usd
CY2021Q4	blco	Related Party Net Borrowings RelatedPartyNetBorrowings	28000000	usd
CY2022	blco	Related Party Cash Pooling And General Financing Activities RelatedPartyCashPoolingAndGeneralFinancingActivities	-226000000	usd
CY2021	blco	Related Party Cash Pooling And General Financing Activities RelatedPartyCashPoolingAndGeneralFinancingActivities	-1317000000	usd
CY2020	blco	Related Party Cash Pooling And General Financing Activities RelatedPartyCashPoolingAndGeneralFinancingActivities	-428000000	usd
CY2022	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	76000000	usd
CY2021	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	390000000	usd
CY2020	blco	Related Party Corporate Allocations RelatedPartyCorporateAllocations	354000000	usd
CY2022	blco	Related Party Benefit From Income Taxes RelatedPartyBenefitFromIncomeTaxes	225000000	usd
CY2021	blco	Related Party Benefit From Income Taxes RelatedPartyBenefitFromIncomeTaxes	302000000	usd
CY2020	blco	Related Party Benefit From Income Taxes RelatedPartyBenefitFromIncomeTaxes	-106000000	usd
CY2022	blco	Related Party Total Net Transfers RelatedPartyTotalNetTransfers	75000000	usd
CY2021	blco	Related Party Total Net Transfers RelatedPartyTotalNetTransfers	-625000000	usd
CY2020	blco	Related Party Total Net Transfers RelatedPartyTotalNetTransfers	-180000000	usd
CY2022	blco	Related Party Payment Of Purchase Debt RelatedPartyPaymentOfPurchaseDebt	2200000000	usd
CY2021	blco	Related Party Payment Of Purchase Debt RelatedPartyPaymentOfPurchaseDebt	0	usd
CY2020	blco	Related Party Payment Of Purchase Debt RelatedPartyPaymentOfPurchaseDebt	0	usd
CY2022	blco	Related Party Net Transfers Allocated Share Based Payment Arrangement Noncash Expense RelatedPartyNetTransfersAllocatedShareBasedPaymentArrangementNoncashExpense	16000000	usd
CY2021	blco	Related Party Net Transfers Allocated Share Based Payment Arrangement Noncash Expense RelatedPartyNetTransfersAllocatedShareBasedPaymentArrangementNoncashExpense	62000000	usd
CY2020	blco	Related Party Net Transfers Allocated Share Based Payment Arrangement Noncash Expense RelatedPartyNetTransfersAllocatedShareBasedPaymentArrangementNoncashExpense	50000000	usd
CY2022	blco	Related Party Net Transfers Other RelatedPartyNetTransfersOther	222000000	usd
CY2021	blco	Related Party Net Transfers Other RelatedPartyNetTransfersOther	43000000	usd
CY2020	blco	Related Party Net Transfers Other RelatedPartyNetTransfersOther	-5000000	usd
CY2022	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	2363000000	usd
CY2021	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	730000000	usd
CY2020	blco	Net Transfers Financing Activities NetTransfersFinancingActivities	225000000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	163000000	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	147000000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	44000000	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	34000000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	421000000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	391000000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	628000000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	572000000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	21000000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	35000000	usd
CY2020	us-gaap	Inventory Write Down InventoryWriteDown	30000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2815000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2549000000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1515000000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1324000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1300000000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1225000000	usd
CY2022	us-gaap	Depreciation Depreciation	135000000	usd
CY2021	us-gaap	Depreciation Depreciation	123000000	usd
CY2020	us-gaap	Depreciation Depreciation	119000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3720000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3360000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	360000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3725000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3159000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	566000000	usd
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5418000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3360000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2058000000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	5423000000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3159000000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2264000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	184000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	89000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	43000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	10000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	9000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	25000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	360000000	usd
CY2019Q4	us-gaap	Goodwill Goodwill	4554000000	usd
CY2020	blco	Goodwill Transfers Related To Sale Of Business Unit GoodwillTransfersRelatedToSaleOfBusinessUnit	10000000	usd
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-121000000	usd
CY2020Q4	us-gaap	Goodwill Goodwill	4685000000	usd
CY2021	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	0	usd
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	99000000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	4586000000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	5000000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	84000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4507000000	usd
CY2021Q2	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	segment
CY2021Q2	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022Q2	us-gaap	Number Of Reporting Units NumberOfReportingUnits	3	segment
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2022Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	196000000	usd
CY2021Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	204000000	usd
CY2022Q4	blco	Accrued Product Rebates Current AccruedProductRebatesCurrent	153000000	usd
CY2021Q4	blco	Accrued Product Rebates Current AccruedProductRebatesCurrent	164000000	usd
CY2022Q4	blco	Accrued Discounts And Allowances Current AccruedDiscountsAndAllowancesCurrent	85000000	usd
CY2021Q4	blco	Accrued Discounts And Allowances Current AccruedDiscountsAndAllowancesCurrent	88000000	usd
CY2022Q4	blco	Accrued Product Returns Current AccruedProductReturnsCurrent	59000000	usd
CY2021Q4	blco	Accrued Product Returns Current AccruedProductReturnsCurrent	60000000	usd
CY2022Q4	blco	Net Borrowings Under Pooled Financing Arrangements Current NetBorrowingsUnderPooledFinancingArrangementsCurrent	0	usd
CY2021Q4	blco	Net Borrowings Under Pooled Financing Arrangements Current NetBorrowingsUnderPooledFinancingArrangementsCurrent	28000000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	408000000	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	316000000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	901000000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	860000000	usd
CY2022	blco	Defined Benefit Plan Estimated Future Benefit Payments Period DefinedBenefitPlanEstimatedFutureBenefitPaymentsPeriod	P10Y
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	119000000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	112000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	26000000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	20000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92000000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	118000000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	112000000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2021Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	0	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	0	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	37000000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	39000000	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	7000000	usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	6000000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	35000000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	29000000	usd
CY2022	blco	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	28000000	usd
CY2021	blco	Rightof Use Asset Obtainedin Exchangefor Operating Lease Liability Excluding Amount Recognized Upon Adoption RightofUseAssetObtainedinExchangeforOperatingLeaseLiabilityExcludingAmountRecognizedUponAdoption	33000000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y6M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y7M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.059
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	32000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	25000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	19000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	15000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	13000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	46000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	150000000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	32000000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	118000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	26000000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	92000000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	17500000	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	56000000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38000000	usd
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30000000	usd
CY2022	blco	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	284000000	usd
CY2021	blco	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	254000000	usd
CY2020	blco	Research And Development Expense Product Related ResearchAndDevelopmentExpenseProductRelated	236000000	usd
CY2022	blco	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	23000000	usd
CY2021	blco	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	17000000	usd
CY2020	blco	Research And Development Expense Quality Assurance ResearchAndDevelopmentExpenseQualityAssurance	17000000	usd
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	307000000	usd
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	271000000	usd
CY2020	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	253000000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	12000000	usd
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2022	us-gaap	Restructuring Charges RestructuringCharges	14000000	usd
CY2021	us-gaap	Restructuring Charges RestructuringCharges	2000000	usd
CY2020	us-gaap	Restructuring Charges RestructuringCharges	2000000	usd
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1000000	usd
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1000000	usd
CY2020	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-6000000	usd
CY2022	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	1000000	usd
CY2021	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	5000000	usd
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	28000000	usd
CY2022	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1000000	usd
CY2021	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2020	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	usd
CY2022	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-5000000	usd
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2022	blco	Other Income Expense Net OtherIncomeExpenseNet	0	usd
CY2021	blco	Other Income Expense Net OtherIncomeExpenseNet	-1000000	usd
CY2020	blco	Other Income Expense Net OtherIncomeExpenseNet	1000000	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-13000000	usd
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-17000000	usd
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-38000000	usd
CY2020	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	28000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-59000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	365000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	387000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	132000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-47000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-97000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	318000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	290000000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	3000000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	109000000	usd
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	122000000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	68000000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	90000000	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	33000000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	71000000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	199000000	usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	155000000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1000000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2000000	usd
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	582000000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-12000000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-72000000	usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-430000000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-13000000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-74000000	usd
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	152000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	307000000	usd
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.265
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	318000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	290000000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	19000000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	86000000	usd
CY2020	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	78000000	usd
CY2022	blco	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	1000000	usd
CY2021	blco	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	-6000000	usd
CY2020	blco	Effective Income Tax Rate Reconciliation Adjustments To Tax Attributes Amount EffectiveIncomeTaxRateReconciliationAdjustmentsToTaxAttributesAmount	2000000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	8000000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2000000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	0	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3000000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2000000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-68000000	usd
CY2022	blco	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-5000000	usd
CY2021	blco	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-15000000	usd
CY2020	blco	Income Tax Reconciliation Uncertain Tax Positions IncomeTaxReconciliationUncertainTaxPositions	-38000000	usd
CY2022	blco	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	6000000	usd
CY2021	blco	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	-1000000	usd
CY2020	blco	Effective Income Tax Rate Reconciliation Withholding Tax Amount EffectiveIncomeTaxRateReconciliationWithholdingTaxAmount	-1000000	usd
CY2022	blco	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-1000000	usd
CY2021	blco	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-5000000	usd
CY2020	blco	Effective Income Tax Rate Reconciliation Return To Provision Amount EffectiveIncomeTaxRateReconciliationReturnToProvisionAmount	-18000000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	34000000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	56000000	usd
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	63000000	usd
CY2022	blco	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	0	usd
CY2021	blco	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	0	usd
CY2020	blco	Income Tax Reconciliation Deferred Intercompany Profit IncomeTaxReconciliationDeferredIntercompanyProfit	284000000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-1000000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	10000000	usd
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5000000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	125000000	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	307000000	usd
CY2022Q4	blco	Deferred Tax Assets Tax Loss And Credit Carryforwards DeferredTaxAssetsTaxLossAndCreditCarryforwards	686000000	usd
CY2021Q4	blco	Deferred Tax Assets Tax Loss And Credit Carryforwards DeferredTaxAssetsTaxLossAndCreditCarryforwards	484000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	210000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	309000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	157000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	151000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	10000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	9000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	28000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	26000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1091000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	979000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	54000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1037000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	962000000	usd
CY2022Q4	blco	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	89000000	usd
CY2021Q4	blco	Deferred Tax Liabilities Basis Difference Of Convertible Notes DeferredTaxLiabilitiesBasisDifferenceOfConvertibleNotes	37000000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	28000000	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Undistributed Foreign Earnings DeferredTaxLiabilitiesUndistributedForeignEarnings	16000000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	117000000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	53000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	920000000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	909000000	usd
CY2022Q4	blco	Unrecognized Tax Benefits Including Interest And Penalties UnrecognizedTaxBenefitsIncludingInterestAndPenalties	70000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	63000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	9000000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	6000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	3000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-1000000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	-2000000	usd
CY2022	blco	Income Tax Number Of Subsidiaries File Federal Income Tax Returns IncomeTaxNumberOfSubsidiariesFileFederalIncomeTaxReturns	1	subsidiary
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	74000000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	62000000	usd
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	100000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	8000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1000000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	48000000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	8000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	11000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	7000000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	42000000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	2000000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	30000000	usd
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	4000000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	70000000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	74000000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	62000000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	350000000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	350000000	shares
CY2022	us-gaap	Net Income Loss NetIncomeLoss	6000000.0	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	182000000.0	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-18000000.0	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000.0	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	350000000.0	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	200000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350200000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350000000.0	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	350000000.0	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.02
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2022	us-gaap	Interest Paid Net InterestPaidNet	132000000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	3000000	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	83000000	usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	53000000	usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	57000000	usd
CY2022Q4	us-gaap	Litigation Reserve Current LitigationReserveCurrent	2000000	usd
CY2022Q4	us-gaap	Contractual Obligation ContractualObligation	36000000	usd
CY2022Q4	blco	Collaborative Agreement Milestone Payments Aggregate CollaborativeAgreementMilestonePaymentsAggregate	129000000	usd
CY2022	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2022	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	244000000	usd
CY2021	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	292000000	usd
CY2020	blco	Amortization Of Intangible Assets Excluding Amortization Allocated To Revenues Cost Of Good Sold AmortizationOfIntangibleAssetsExcludingAmortizationAllocatedToRevenuesCostOfGoodSold	323000000	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-13000000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-17000000	usd
CY2020	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-38000000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	207000000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	329000000	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	260000000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	6000000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	0	usd
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	3000000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	146000000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6000000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-11000000	usd
CY2020	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	73000000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	318000000	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	290000000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	175000000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	193000000	usd
CY2020	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	253000000	usd
CY2022	blco	Concentration Risk Number Of Products Franchises ConcentrationRiskNumberOfProductsFranchises	10	product
CY2021	blco	Concentration Risk Number Of Products Franchises ConcentrationRiskNumberOfProductsFranchises	10	product
CY2020	blco	Concentration Risk Number Of Products Franchises ConcentrationRiskNumberOfProductsFranchises	10	product
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3768000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3765000000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3412000000	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3768000000	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3765000000	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3412000000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1300000000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1225000000	usd

Files In Submission

Name	View Source	Status
blco-20221231_cal.xml	Edgar Link	unprocessable
0001860742-23-000008-index-headers.html	Edgar Link	pending
0001860742-23-000008-index.html	Edgar Link	pending
0001860742-23-000008.txt	Edgar Link	pending
0001860742-23-000008-xbrl.zip	Edgar Link	pending
blco-20221231.htm	Edgar Link	pending
blco-20221231.xsd	Edgar Link	pending
blco-20221231_g1.jpg	Edgar Link	pending
exhibit1025-arseparationag.htm	Edgar Link	pending
exhibit1032-mrsugrantagree.htm	Edgar Link	pending
exhibit1035-employmentagre.htm	Edgar Link	pending
exhibit211ye2022.htm	Edgar Link	pending
exhibit231ye2022.htm	Edgar Link	pending
exhibit311ye2022.htm	Edgar Link	pending
exhibit312ye2022.htm	Edgar Link	pending
exhibit321ye2022.htm	Edgar Link	pending
exhibit322ye2022.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
blco-20221231_def.xml	Edgar Link	unprocessable
blco-20221231_lab.xml	Edgar Link	unprocessable
blco-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
blco-20221231_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BLCO
Bausch & Lomb Corp Stock $blco

2023 Q1 Form 10-K Financial Statement

#000186074223000008 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLCO Bausch & Lomb Corp Stock $blco

2023 Q1 Form 10-K Financial Statement

#000186074223000008 Filed on February 22, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BLCO
Bausch & Lomb Corp Stock $blco